ALB and Hepatic fibrosis: This study aimed to investigate the association of LC9 with MASLD and hepatic fibrosis and to reveal for the first time the mediating role of a novel inflammatory marker, neutrophil percentage-to-albumin ratio (NPAR), in the association between LC9 and MASLD.